Terry Van Vleet

450 total citations
11 papers, 347 citations indexed

About

Terry Van Vleet is a scholar working on Molecular Biology, Biomedical Engineering and Cell Biology. According to data from OpenAlex, Terry Van Vleet has authored 11 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Biomedical Engineering and 2 papers in Cell Biology. Recurrent topics in Terry Van Vleet's work include Pluripotent Stem Cells Research (3 papers), 3D Printing in Biomedical Research (2 papers) and RNA modifications and cancer (1 paper). Terry Van Vleet is often cited by papers focused on Pluripotent Stem Cells Research (3 papers), 3D Printing in Biomedical Research (2 papers) and RNA modifications and cancer (1 paper). Terry Van Vleet collaborates with scholars based in United States, Germany and Switzerland. Terry Van Vleet's co-authors include Xiuli Liu, Rick G. Schnellmann, Thomas P. Sanderson, Mark A. Dominick, Sarah H. Tannehill‐Gregg, Samuel M. Cohen, M. Cano, Radhakrishna Sura, Brian R. Berridge and Claire G. Jeong and has published in prestigious journals such as The FASEB Journal, The Annual Review of Pharmacology and Toxicology and Toxicology.

In The Last Decade

Terry Van Vleet

10 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terry Van Vleet United States 4 196 72 63 43 38 11 347
Patrik Strömberg Sweden 13 185 0.9× 20 0.3× 48 0.8× 36 0.8× 44 1.2× 20 456
Dipankar Ash United States 9 159 0.8× 32 0.4× 26 0.4× 69 1.6× 67 1.8× 12 424
Zuzana Solárová Slovakia 10 155 0.8× 48 0.7× 18 0.3× 39 0.9× 21 0.6× 22 424
Xian‐Yang Qin Japan 14 250 1.3× 32 0.4× 26 0.4× 36 0.8× 41 1.1× 38 475
Meiyuan Huang China 11 158 0.8× 28 0.4× 41 0.7× 24 0.6× 32 0.8× 27 351
Xiaojie Li China 13 193 1.0× 28 0.4× 24 0.4× 49 1.1× 29 0.8× 32 363
Woong‐Hee Kim South Korea 11 243 1.2× 20 0.3× 40 0.6× 35 0.8× 32 0.8× 17 383
Denise Lee Singapore 8 232 1.2× 49 0.7× 22 0.3× 30 0.7× 64 1.7× 23 430
Marije Niemeijer Netherlands 10 168 0.9× 31 0.4× 75 1.2× 25 0.6× 58 1.5× 19 340

Countries citing papers authored by Terry Van Vleet

Since Specialization
Citations

This map shows the geographic impact of Terry Van Vleet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Van Vleet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Van Vleet more than expected).

Fields of papers citing papers by Terry Van Vleet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Van Vleet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Van Vleet. The network helps show where Terry Van Vleet may publish in the future.

Co-authorship network of co-authors of Terry Van Vleet

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Van Vleet. A scholar is included among the top collaborators of Terry Van Vleet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Van Vleet. Terry Van Vleet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Reynolds, Vincent L., Paul Butler, Laura Aschenbrenner, et al.. (2020). Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective. Regulatory Toxicology and Pharmacology. 117. 104746–104746. 1 indexed citations
2.
Sura, Radhakrishna, Terry Van Vleet, & Brian R. Berridge. (2020). Microphysiological Systems: A Pathologist’s Perspective. Veterinary Pathology. 57(3). 358–368. 7 indexed citations
3.
Ewart, Lorna, Kristin Fabre, Yvonne P. Dragan, et al.. (2017). Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective. Experimental Biology and Medicine. 242(16). 1579–1585. 67 indexed citations
4.
Rao, Mohan, Michael J. Liguori, Srinivasa R. Mantena, et al.. (2017). Computational Prediction of Off‐Target Pharmacology for Discontinued Drugs. The FASEB Journal. 31(S1). 2 indexed citations
5.
Simic, Damir, Emily R. Haines, Aiqing He, et al.. (2013). MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459. Toxicology. 311(3). 169–177. 3 indexed citations
6.
Zheng, Naiyu, Mark E. Arnold, Zheng Ouyang, et al.. (2013). A simplified and completely automated workflow for regulated LC–MS/MS bioanalysis using cap-piercing direct sampling and evaporation-free solid phase extraction. Journal of Chromatography B. 921-922. 64–74. 3 indexed citations
7.
Simic, Damir, et al.. (2013). Determination of Relative Notch1 and γ-Secretase-Related Gene Expression in Puromycin-Treated Microdissected Rat Kidneys. Gene Expression. 16(1). 39–47. 2 indexed citations
8.
Simic, Damir, et al.. (2012). Assessing Cell Fusion and Cytokinesis Failure as Mechanisms of Clone 9 Hepatocyte Multinucleation In Vitro. Current Protocols in Toxicology. 53(1). Unit 14.9.1–17. 3 indexed citations
9.
10.
Dominick, Mark A., Thomas P. Sanderson, Terry Van Vleet, et al.. (2006). Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action. Toxicologic Pathology. 34(7). 903–920. 73 indexed citations
11.
Liu, Xiuli, Terry Van Vleet, & Rick G. Schnellmann. (2004). The Role of Calpain in Oncotic Cell Death. The Annual Review of Pharmacology and Toxicology. 44(1). 349–370. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrik Strömberg Breakdown of academic impact, for papers by Dipankar Ash Breakdown of academic impact, for papers by Zuzana Solárová Breakdown of academic impact, for papers by Xian‐Yang Qin Breakdown of academic impact, for papers by Meiyuan Huang Breakdown of academic impact, for papers by Xiaojie Li Breakdown of academic impact, for papers by Woong‐Hee Kim Breakdown of academic impact, for papers by Denise Lee Breakdown of academic impact, for papers by Marije Niemeijer
Rankless by CCL
2026